Rural survivors were more likely to experience chronic pain than urban survivors, at rates of 43.0% and 33.5%, respectively. After controlling for several factors, the investigators found that rural ...

Intensity-modulated proton therapy (IMPT) improves overall survival (OS) and reduces high-grade toxicity compared with intensity-modulated radiation ...

Researchers compared the safety and efficacy of BrECADD vs eBEACOPP, a standard regimen, in the newly diagnosed, advanced-stage classical HL setting. Researchers determined the BrECADD combination ...

The Food and Drug Administration (FDA) has approved Rybrevant Faspro™, a subcutaneous (SC) formulation of amivantamab for all indications approved for the ...

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

TRITON3 trial data support FDA traditional approval of rucaparib for treating adults with BRCA-mutated metastatic castration-resistant prostate cancer.

Investigators sought to determine whether alcohol intake, particularly at higher frequency or greater quantity, was consistently associated with elevated risk for cancer.

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

In this analysis of colorectal cancer patients from 2 clinical trials, researchers aimed to assess the effect of physical activity on overall survival.

Researchers sought to determine whether zanubrutinib plus obinutuzumab would be effective in treating patients with R/R FL. Researchers determined zanubrutinib plus obinutuzumab demonstrated sustained ...

In this analysis, researchers aimed to determine which factors play a role in cardiovascular risk in childhood cancer survivors.